Cancer Letters
Volume 246, Issue 1 , Pages 210-217 , 8 February 2007

Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha extracts

Received 31 January 2006 ,Revised 31 January 2006 ,Accepted 20 February 2006.

References 

  1. Ghia P, Nadler LM. Recent advances in lymphoma biology. Curr. Opin. Oncol. 1997;9:403–412
  2. Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanism. Acta Pharmacol. Sinica. 2004;25:1387–1395
  3. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol. 1992;37:101–134
  4. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol. 1999;19:65–96
  5. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyad FP, Ho NWY. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem. Biophys. Res. Commum. 2002;298:603–612
  6. Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int. J. Oncol. 2004;24:1093–1099
  7. Lee IR, Yang MY. Phenolic compounds from Duchesnea chrysantha and their cytotoxic activities in human cancer cell. Arch. Pharm. Res. 1994;17:476–479
  8. Kim IG, Jung IL, Oh TJ, Kim KC, Shim HW. Polysaccharide-enriched fraction isolated from Duchesnea chrysantha protects against oxidative damage. Biotech. Lett. 2002;24:1299–1305
  9. Zhu M, Chang Q, Wong LK, Chong FS, Li RC. Triterpene antioxidants from Ganoderma lucidum. Phytother. Res. 1999;13:529–531
  10. Wang S-Y, Chen L-Y, Wang S-J, Lin CK, Ho C-K. Growth inhibition and differentiation in HL-60 leukemia cells induced by 1,25-dihydroxyvitamin D3 and tumor necrosis factor alpha. Exp. Hematol. 1991;19:1025–1030
  11. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 1991;162:261–268
  12. Bradbury DA, Simmons TD, Slater KJ, Crouch SPM. Measurement of ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. J. Immunol. Methods. 2000;240:79–92
  13. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluororimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1.1′,3,3′-tetrataethyl-benzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 1993;197:40–45
  14. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol. Today. 1997;18:44–51
  15. Pastorino JG, Chen S-T, Tafani M, Snyder JW, Farber JL. The overexpression of bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 1998;273:7770–7775
  16. Smaili SS, Hsu Y-T, Sanders KM, Russell JT, Youle RJ. Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ. 2001;8:909–920
  17. Hsu Y-T, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc. Natl Acad. Sci. USA. 1997;94:3668–3672
  18. Jia L, Macey MG, Yin Y, Newland AC, Kelsey SM. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood. 1999;93:2353–2359
  19. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132–1136
  20. Mow BM, Blajeski AL, Chandra J, Kaufmann SH. Apoptosis and the response to anticancer therapy. Curr. Opin. Oncol. 2001;13:453–462
  21. Fulda S, Susin SA, Kroemer G, Debatin KM. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 1998;58:4453–4460
  22. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312

PII: S0304-3835(06)00122-4

doi: 10.1016/j.canlet.2006.02.014

Cancer Letters
Volume 246, Issue 1 , Pages 210-217 , 8 February 2007

Article Tools

* Image Usage & Resolution